US Stock MarketDetailed Quotes

ANRO Alto Neuroscience

Watchlist
  • 3.830
  • 0.0000.00%
Close Dec 13 16:00 ET
  • 3.800
  • -0.030-0.78%
Post 20:01 ET
103.30MMarket Cap-1.80P/E (TTM)

About Alto Neuroscience Company

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Company Profile

SymbolANRO
Company NameAlto Neuroscience
Listing DateFeb 2, 2024
Issue Price16.00
Founded2019
CEODr. Amit Etkin, M.D.
MarketNYSE
Employees63
Fiscal Year Ends12-31
Address650 Castro Street,Suite 450
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94041
Phone1-650-200-0412
Websitehttp://www.altoneuroscience.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Amit Etkin, M.D.
  • President, Chief Executive Officer and Chairman of the Board
  • 1.86M
  • Adam Savitz
  • Chief Medical Officer
  • 1.24M
  • Nicholas Conrad Smith
  • Chief Financial Officer and Principal Accounting Officer
  • 1.60M
  • Michael Conick Hanley, Jr
  • Chief Operating Officer
  • --
  • Gwill York
  • Independent Director
  • 53.68K
  • Christopher Nixon Cox
  • Independent Director
  • --
  • Dr. Po Yu Chen
  • Independent Director
  • --
  • Mahalakshmi Radhakrishnan, M.D.
  • Independent Director
  • --
  • Andrew Dreyfus
  • Independent Director
  • 107.37K
  • Dr. Husseini Manji
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data